Welcome to the CJU website » LOG IN


Germline contributions to metastatic prostate cancer
Department of Medicine, University of Washington, Seattle, Washington, USA
Oct  2019 (Vol.  26, Issue  52, Pages( 19 - 21)
PMID: 31629420


Text-Size + 

  • Recent studies demonstrate that the prevalence of germline mutations in DNA repair genes in metastatic prostate cancer is higher than previously recognized, and is higher than in localized disease and in unaffected men. This is compelling evidence that specific gene dysfunction is critical in prostate cancer initiation and/or evolution to metastases. Applications to treatment in advanced disease are imminent, and further investigation in early-stage disease, as well as in diverse and at-risk populations will help maximize clinical benefit.